FI113370B - Naftyyliamidit keskushermostoaineina, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset - Google Patents
Naftyyliamidit keskushermostoaineina, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset Download PDFInfo
- Publication number
- FI113370B FI113370B FI963294A FI963294A FI113370B FI 113370 B FI113370 B FI 113370B FI 963294 A FI963294 A FI 963294A FI 963294 A FI963294 A FI 963294A FI 113370 B FI113370 B FI 113370B
- Authority
- FI
- Finland
- Prior art keywords
- ethyl
- methoxy
- piperazinyl
- bromo
- naphthalenecarboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Liquid Carbonaceous Fuels (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/217,395 US5395835A (en) | 1994-03-24 | 1994-03-24 | Naphthalamides as central nervous system agents |
| US21739594 | 1994-03-24 | ||
| US9501974 | 1995-02-16 | ||
| PCT/US1995/001974 WO1995025727A1 (en) | 1994-03-24 | 1995-02-16 | Naphthylamides as central nervous system agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI963294A0 FI963294A0 (fi) | 1996-08-23 |
| FI963294A FI963294A (fi) | 1996-08-23 |
| FI113370B true FI113370B (fi) | 2004-04-15 |
Family
ID=22810896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI963294A FI113370B (fi) | 1994-03-24 | 1996-08-23 | Naftyyliamidit keskushermostoaineina, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5395835A (no) |
| EP (1) | EP0751939B9 (no) |
| JP (1) | JP3771581B2 (no) |
| KR (1) | KR100366175B1 (no) |
| AT (1) | ATE219068T1 (no) |
| AU (1) | AU683358B2 (no) |
| BG (1) | BG62887B1 (no) |
| CZ (1) | CZ284377B6 (no) |
| DE (1) | DE69527053T2 (no) |
| DK (1) | DK0751939T5 (no) |
| ES (1) | ES2178668T4 (no) |
| FI (1) | FI113370B (no) |
| HU (1) | HUT76058A (no) |
| MX (1) | MX9602517A (no) |
| NO (1) | NO306779B1 (no) |
| NZ (1) | NZ281824A (no) |
| PH (1) | PH31335A (no) |
| PL (1) | PL181270B1 (no) |
| PT (1) | PT751939E (no) |
| RO (1) | RO117452B1 (no) |
| RU (1) | RU2157370C2 (no) |
| WO (1) | WO1995025727A1 (no) |
| ZA (1) | ZA952382B (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
| PT732332E (pt) * | 1995-03-17 | 2002-06-28 | Aventis Pharma Inc | Benzotienilpiperazinas substituidas sua utilizacao como medicamentos e processos para a sua preparacao |
| FR2738569B1 (fr) * | 1995-09-12 | 1997-11-28 | Pf Medicament | Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique |
| US5659033A (en) * | 1995-09-13 | 1997-08-19 | Neurogen Corporation | N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| FR2742149B1 (fr) * | 1995-12-11 | 1998-02-13 | Inst Nat Sante Rech Med | Nouveaux derives de 2-naphtamides et leurs applications therapeutiques |
| US5710274A (en) * | 1996-02-28 | 1998-01-20 | Neurogen Corporation | N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands |
| US5763609A (en) * | 1996-03-21 | 1998-06-09 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands |
| US5703235A (en) * | 1996-03-21 | 1997-12-30 | Neurogen Corporation | N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| US5703083A (en) * | 1996-04-15 | 1997-12-30 | Neurogen Corporation | N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands |
| US5703237A (en) * | 1996-04-18 | 1997-12-30 | Neurogen Corporation | N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands |
| US5688950A (en) * | 1996-04-23 | 1997-11-18 | Neurogen Corporation | Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands |
| US5892041A (en) * | 1996-08-12 | 1999-04-06 | Neurogen Corporation | Fused indolecarboxamides: dopamine receptor subtype specific ligands |
| US6426415B1 (en) | 1997-09-03 | 2002-07-30 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity |
| US6197785B1 (en) | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
| US6291425B1 (en) * | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| US6346536B1 (en) | 1997-09-03 | 2002-02-12 | Guilford Pharmaceuticals Inc. | Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same |
| US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| JP2002515488A (ja) * | 1998-05-15 | 2002-05-28 | ギルフォード ファーマシューティカルズ インコーポレイテッド | カルボキサミド化合物、組成物、及びｐａｒｐ活性の抑制方法 |
| US6395749B1 (en) | 1998-05-15 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| US6387902B1 (en) | 1998-12-31 | 2002-05-14 | Guilford Pharmaceuticals, Inc. | Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP |
| ATE402704T1 (de) * | 2000-03-27 | 2008-08-15 | Abbott Gmbh & Co Kg | Dopamin-d3-rezeptor-liganden zur behandlung von sucht |
| US6723733B2 (en) | 2000-05-19 | 2004-04-20 | Guilford Pharmaceuticals, Inc. | Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses |
| WO2001091796A2 (en) | 2000-06-01 | 2001-12-06 | Guilford Pharmaceuticals Inc. | Methods, compounds and compositions for treating gout |
| AU2001273099A1 (en) | 2000-07-13 | 2002-01-30 | Guilford Pharmaceuticals Inc. | Substituted 4,9-dihydrocyclopenta(imn) phenanthridine-5-ones, derivatives thereof and their uses |
| CA2438316A1 (en) * | 2001-02-16 | 2002-08-29 | Aventis Pharmaceuticals Inc. | Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| EP1688412A3 (en) * | 2001-02-16 | 2006-08-16 | Aventis Pharmaceuticals, Inc. | Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| EP1509213A2 (en) * | 2002-05-23 | 2005-03-02 | Abbott Laboratories | Acetamides and benzamides that are useful in treating sexual dysfunction |
| EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| KR20230001660U (ko) | 2022-02-08 | 2023-08-16 | 주식회사 승진피엘에스 | 옷걸이용 지주 고정장치 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1543944A (fr) * | 1967-03-10 | 1968-10-31 | Bruneau & Cie Lab | Dérivés amidés de l'acide salicylique et leur préparation |
| US3846430A (en) * | 1968-01-12 | 1974-11-05 | Bruneau & Cie Lab | 1-(2-methoxy-phenyl)-4-{8 2-(4-fluoro-benzamido)-ethyl{9 -piperazine |
| US4975439A (en) * | 1987-09-25 | 1990-12-04 | Janssen Pharmaceutical N.V. | Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
| US5010078A (en) * | 1988-05-24 | 1991-04-23 | American Home Products Corporation | Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity |
| CA1340113C (en) * | 1988-05-24 | 1998-11-03 | Magid A. Abou-Gharbia | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
| JP2671059B2 (ja) * | 1990-11-30 | 1997-10-29 | 富士レビオ株式会社 | ナフトエ酸誘導体 |
| FR2682953B1 (fr) * | 1991-10-23 | 1995-04-21 | Inst Nat Sante Rech Med | Nouveaux derives de naphtamides, leur procede de preparation et leur application dans le domaine therapeutique. |
| SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
| FR2693722B1 (fr) * | 1992-07-16 | 1994-10-14 | Meram Lab | Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant. |
| GB9218113D0 (en) * | 1992-08-26 | 1992-10-14 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1994
- 1994-03-24 US US08/217,395 patent/US5395835A/en not_active Expired - Fee Related
-
1995
- 1995-02-16 PL PL95316313A patent/PL181270B1/pl not_active IP Right Cessation
- 1995-02-16 EP EP95911021A patent/EP0751939B9/en not_active Expired - Lifetime
- 1995-02-16 RU RU96119964/04A patent/RU2157370C2/ru not_active IP Right Cessation
- 1995-02-16 HU HU9602605A patent/HUT76058A/hu unknown
- 1995-02-16 PT PT95911021T patent/PT751939E/pt unknown
- 1995-02-16 MX MX9602517A patent/MX9602517A/es not_active IP Right Cessation
- 1995-02-16 DK DK95911021T patent/DK0751939T5/da active
- 1995-02-16 AU AU18774/95A patent/AU683358B2/en not_active Ceased
- 1995-02-16 CZ CZ962768A patent/CZ284377B6/cs not_active IP Right Cessation
- 1995-02-16 DE DE69527053T patent/DE69527053T2/de not_active Expired - Fee Related
- 1995-02-16 ES ES95911021T patent/ES2178668T4/es not_active Expired - Lifetime
- 1995-02-16 WO PCT/US1995/001974 patent/WO1995025727A1/en active IP Right Grant
- 1995-02-16 NZ NZ281824A patent/NZ281824A/en unknown
- 1995-02-16 RO RO96-01853A patent/RO117452B1/ro unknown
- 1995-02-16 KR KR1019960705267A patent/KR100366175B1/ko not_active IP Right Cessation
- 1995-02-16 AT AT95911021T patent/ATE219068T1/de not_active IP Right Cessation
- 1995-02-16 JP JP52463695A patent/JP3771581B2/ja not_active Expired - Fee Related
- 1995-03-21 PH PH50161A patent/PH31335A/en unknown
- 1995-03-23 ZA ZA952382A patent/ZA952382B/xx unknown
-
1996
- 1996-08-23 FI FI963294A patent/FI113370B/fi not_active IP Right Cessation
- 1996-09-05 BG BG100830A patent/BG62887B1/bg unknown
- 1996-09-23 NO NO963996A patent/NO306779B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI113370B (fi) | Naftyyliamidit keskushermostoaineina, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| AU2003283265B2 (en) | 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity | |
| US6548504B1 (en) | Compounds | |
| FR2722788A1 (fr) | Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant | |
| JP2000516936A (ja) | ドパミンｄ２作動薬としておよび５―ｈｔ１ａリガンドとしての４―アミノエトキシインドール | |
| CN101228138A (zh) | 神经治疗吡咯化合物 | |
| CZ20024199A3 (cs) | Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru | |
| JP2005501019A (ja) | ５−ｈｔ６レセプター親和性を有する４−ピペラジニルインドール誘導体 | |
| TWI298636B (en) | Arylsulfonyl benzodioxanes and methods of use | |
| WO1998031669A1 (fr) | Nouvelles arylpiperazines derivees de piperidine comme medicaments antidepresseurs | |
| KR100860692B1 (ko) | 축합 환식기를 가지는 환상 디아민 화합물 | |
| CA2320120C (en) | Benzisoxazole derivatives having d4-antagonistic activity | |
| GB2352240A (en) | Novel sulphonamides useful in treating CNS disorders | |
| JP2002509135A (ja) | 神経細胞カルシウムチャンネルの活性の調節剤としてのアミノスルホニルベンズアミド誘導体 | |
| MX2007013274A (es) | Ligandos del receptor de histamina h3 y su aplicacion terapeutica. | |
| US5958965A (en) | 4-aminoethoxy indoles | |
| PT775113E (pt) | Derivados do azabicicloheptano substituidos no azoto com uso como substancias neurolepticas | |
| CA2180155C (en) | Naphthylamides as central nervous system agents | |
| US6586592B2 (en) | Bis-arylsulfones | |
| ZA200204464B (en) | Heteroaryl derivatives, their preparation and use. | |
| TW200800163A (en) | Arylsulfonyl chromans as 5-HT6 inhibitors | |
| US20040014966A1 (en) | Bis-arylsulfones | |
| PL181831B1 (pl) | Farmakologicznie aktywne enancjomery PL PL PL PL PL | |
| JPH02264780A (ja) | α―アドレナリン作動性受容体拮杭剤 | |
| PT1519726E (pt) | Utilização de carboxamidas de heteroareno como ligandos de dopamina-d3 para o tratamento de patalogias do snc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |